Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma

Cancer Immunology, Immunotherapy

Volumn 63, Issue 3, 2014, Pages 297-303

  Sznurkowski, Jacek Jan ^a   Åawrocki, Anton ^a   Biernat, Wojciech ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

CD56+; Granzyme B; Prognosis; TILs; vSCC; Vulvar cancer

Indexed keywords

ADAPTIVE IMMUNITY; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD56; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GRANZYMES; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHATIC METASTASIS; LYMPHOCYTE SUBSETS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; T-LYMPHOCYTES, CYTOTOXIC; VULVAR NEOPLASMS;

EID: 84894471207     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-013-1511-x     Document Type: Article

References (33)

1. Sturgeon SR, Bronton LA, Devesa SS, Kurman RJ (1992) In situ and invasive vulvar cancer incidence trends (1973-1987). Am J Obstet Gynecol 166(5):1482-1485
2. Ansink AC, Heintz AP (1993) Epidemiology and etiology of squamous cell carcinoma of the vulva. Eur J Obstet Gynecol Reprod Biol 48(2):111-115
3. Coulter J, Gleeson N (2003) Local and regional recurrence of vulval cancer: management dilemmas. Best Pract Res Clin Obstet Gynaecol 17(4):663-681
4. Monaghan JM (1990) The management of carcinoma of the vulva. In: Shepherd JH, Monaghan JM (eds) Clinical gynecologiconcology, 2nd edn. Blackwell, Oxford, pp 140-167
5. Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY, Maisonneuve P, Pecorelli S, Odicino F, Heintz AP (2006) Carcinoma of the vulva FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet. 95 Suppl 1:S7-S27
6. Maggino T, Landoni F, Sartori E, Zola P, Gadducci A, Alessi C, Soldà M, Coscio S, Spinetti G, Maneo A, Ferrero A, Konishi De Toffoli G (2000) Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study. Cancer 89(1):116-122
7. Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR (2006) Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol 60(3):227-241
8. Rosenberg SA (2001) Prognosis in human tumor immunology and immunotherapy. Nature 411(6835):380-384
9. Abbas AK, Lichtman AH, Pober JS (1997) Immunity to tumors. In: Abbas AK, Lichtman AH, Pober JS (eds) Cellular and molecular immunology. WB Saunders, Philadelphia, pp 382-405
10. Provinciali M (2009) Immunosenescence and cancer vaccines. Cancer Immunol Immunother 58(12):1959-1967. doi: 10.1007/s00262-009-0665
11. Whiteside TL, Vojanovic NL, Herberman RB (1998) Natural killer cells and tumor therapy. Curr Top Microbiol Immunol 230:221-244
12. Rousalova I, Krepela E (2010) Granzyme B-induced apoptosis in cancer cells and its regulation (review). Int J Oncol 37(6):1361-1378
13. Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ (2004) Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and Tregulatory cells. Blood 104(9):2840-2848
14. + T cells infiltration within cancer cell nests in vulvar squamous cell carcinoma. Int J Gynecol Cancer 21(4):717-721. doi: 10.1097/IGC.0b013e3182131f36
15. Sznurkowski JJ, Zawrocki A, Emerich J, Sznurkowska K, Biernat W (2011) Expression of indoleamine 2,3-dioxygenase predicts shorter survival in patients with vulvar squamous cell carcinoma (vSCC) not influencing on the recruitment of FOXP3-expressing regulatory T cells in cancer nests. Gynecol Oncol 122(2):307-312. doi: 10.1016/j.ygyno.2011.04.050
16. de Jong RA, Toppen NL, Ten Hoor KA, Boezen HM, Kema IP, Hollema H, Nijman HW (2012) Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma. Gynecol Oncol 125(1):186-193. doi: 10.1016/j.ygyno.2011.12. 416
17. Yoshida N, Abe H, Ohkuri O et al (2006) Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance. Int J Oncol 28(5):1089-1098
18. Wakabayashi O, Yamazaki K, Oizumi S et al (2003) CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell cancers. Cancer Sci 94(11):1003-1009
19. Mansfield AS, Heikkila PS, Vaara AT, von Smitten KA, Vakkila JM, Leidenius MH (2009) Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 15(9):231. doi: 10.1186/1471-2407-9-231
20. Sznurkowski JJ (2012) Comments on manuscript entitled "Status of cellular immunity lacks prognostic significance in vulvar squamous carcinoma" by de Jong RA et al. Gynecol Oncol. Gynecol Oncol 125(3):767-768. doi: 10.1016/j.ygyno.2011.12.416
21. Sznurkowski JJ (2012) Author's reply; doi: 10.1016/j.ygyno.2012.02.036
22. Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45):5904-5912
23. Afonina IS, Cullen SP, Martin SJ (2010) Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol Rev 235(1):105-116
24. Smyth MJ, Crowe NY, Hayakawa Y, Takeda K, Yagita H, Godfrey DI (2002) NKT cells - conductors of tumor immunity? Curr Opin Immunol 14(2):165-171
25. Smyth MJ, Hayakawa Y, Takeda K, Yagita H (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2(11):850-861
26. Lanier LL (2003) Natural killer cell receptor signaling. Curr Opin Immunol 15(3):308-314
27. Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagitab H et al (2002) Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat Immunol 3(1):83-90
28. Vujanovic NL, NagashimaS HR, Whiteside TL (1996) Non-secretory apoptotic killing by human natural killer cells. J Immunol 157(3):1117-1126
29. Whiteside TL (2010) Immune responses to malignancies. J Allergy Clin Immunol 125(2 Suppl 2):272-283. doi: 10.1016/j.jaci.2009.09.045
30. Borrego F, Alonso MC, Galiani MD, Carracedo J, Ramirez R, Ostos B et al (1999) NK phenotypic markers and IL2 response in NK cells from elderly people. Exp Gerontol 34(2):253-265
31. Kutza J, Murasko DM (1996) Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech Ageing Dev 90(3):209-222
32. Mariani E, Roda P, Mariani AR, Vitale M, Degrassi A, Papa S et al (1990) Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Clin Exp Immunol 81(3):479-484
33. Fernandes G, Gupta S (1981) Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J Clin Immunol 1(13):141-148